192 related articles for article (PubMed ID: 6751921)
21. [Antineoplastic activity of L-asparaginase].
Grgić Z
Lijec Vjesn; 1969 Jul; 91(7):783-6. PubMed ID: 4910066
[No Abstract] [Full Text] [Related]
22. Factors which may influence the effectiveness of L-asparaginases as tumor inhibitors.
Broome JD
Br J Cancer; 1968 Sep; 22(3):595-602. PubMed ID: 4878639
[No Abstract] [Full Text] [Related]
23. The effect of asparaginase on some animal-tumors.
Connors TA; Jones M
Recent Results Cancer Res; 1970; 33():180-7. PubMed ID: 4949161
[No Abstract] [Full Text] [Related]
24. Enhancement of asparaginase-induced regression of the 6C3HED lymphosarcoma by protein-free diet.
Ryan WL; Sornson HC
Cancer Res; 1973 May; 33(5):1062-4. PubMed ID: 4574058
[No Abstract] [Full Text] [Related]
25. High efficacy of monomethoxypolyethylene glycol-conjugated L-asparaginase (PEG2-ASP) in two patients with hematological malignancies.
Kawashima K; Takeshima H; Higashi Y; Hamaguchi M; Sugie H; Imamura I; Wada H
Leuk Res; 1991; 15(6):525-30. PubMed ID: 1861535
[TBL] [Abstract][Full Text] [Related]
26. Principal biochemical characteristics of the EC-2 L-asparaginase from Escherichia coli AT.
Smékal F
Neoplasma; 1969; 16(4):469-70. PubMed ID: 4899032
[No Abstract] [Full Text] [Related]
27. A new L-asparaginase with antitumour activity?
Wade HE; Elsworth R; Herbert D; Keppie J; Sargeant K
Lancet; 1968 Oct; 2(7571):776-7. PubMed ID: 4175572
[No Abstract] [Full Text] [Related]
28. Synthesis, characterization and immunogenicity of silk fibroin-L-asparaginase bioconjugates.
Zhang YQ; Zhou WL; Shen WD; Chen YH; Zha XM; Shirai K; Kiguchi K
J Biotechnol; 2005 Nov; 120(3):315-26. PubMed ID: 16102867
[TBL] [Abstract][Full Text] [Related]
29. Immunological and pharmacological characterization of poly-DL-alanyl-modified Erwinia carotovora L-asparaginase.
Uren JR; Hargis BJ; Beardsley P
Cancer Res; 1982 Oct; 42(10):4068-71. PubMed ID: 7105004
[TBL] [Abstract][Full Text] [Related]
30. Chemical modification of L-asparaginase from Cladosporium sp. for improved activity and thermal stability.
Mohan Kumar NS; Kishore V; Manonmani HK
Prep Biochem Biotechnol; 2014; 44(5):433-50. PubMed ID: 24397716
[TBL] [Abstract][Full Text] [Related]
31. The effects of immunization to L-asparaginase on antitumor and enzymatic activity.
Goldberg AI; Cooney DA; Glynn JP; Homan ER; Gaston MR; Milman HA
Cancer Res; 1973 Feb; 33(2):256-61. PubMed ID: 4569788
[No Abstract] [Full Text] [Related]
32. Molecular design of hybrid tumor necrosis factor-alpha III: polyethylene glycol-modified tumor necrosis factor-alpha has markedly enhanced antitumor potency due to longer plasma half-life and higher tumor accumulation.
Tsutsumi Y; Kihira T; Tsunoda S; Kamada H; Nakagawa S; Kaneda Y; Kanamori T; Mayumi T
J Pharmacol Exp Ther; 1996 Sep; 278(3):1006-11. PubMed ID: 8819479
[TBL] [Abstract][Full Text] [Related]
33. [Antibody sandwich enzyme-linked immunoadsorbent assay for determination of recombinant E. coli L-asparaginase in rat plasma and its pharmacokinetics].
Chen JH; Wu WT; Kazuyuki H
Yao Xue Xue Bao; 2003 Aug; 38(8):613-6. PubMed ID: 14628454
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of blastogenesis by native and polyethylene glycol-modified asparaginases from Escherichia coli and Vibrio succinogenes.
Bendich A; Kafkewitz D; Abuchowski A; Davis FF
Immunol Commun; 1983; 12(3):273-84. PubMed ID: 6350165
[TBL] [Abstract][Full Text] [Related]
35. Optimizing asparaginase therapy for acute lymphoblastic leukemia.
Rizzari C; Conter V; Starý J; Colombini A; Moericke A; Schrappe M
Curr Opin Oncol; 2013 Mar; 25 Suppl 1():S1-9. PubMed ID: 23380829
[TBL] [Abstract][Full Text] [Related]
36. Polyethylene glycol-L-asparaginase and L-asparaginase studies in rabbits.
Ho DH; Wang CY; Lin JR; Brown N; Newman RA; Krakoff IH
Drug Metab Dispos; 1988; 16(1):27-9. PubMed ID: 2894951
[TBL] [Abstract][Full Text] [Related]
37. A Phase I-II trial of polyethylene glycol-conjugated L-asparaginase in patients with multiple myeloma.
Agrawal NR; Bukowski RM; Rybicki LA; Kurtzberg J; Cohen LJ; Hussein MA
Cancer; 2003 Jul; 98(1):94-9. PubMed ID: 12833461
[TBL] [Abstract][Full Text] [Related]
38. Crystalline L-asparaginase from escherichia coli B.
Ho PP; Frank BH; Burck PJ
Science; 1969 Aug; 165(3892):510-2. PubMed ID: 4894591
[TBL] [Abstract][Full Text] [Related]
39. Antitumor enzyme: polyethylene glycol-modified asparaginase.
Wada H; Imamura I; Sako M; Katagiri S; Tarui S; Nishimura H; Inada Y
Ann N Y Acad Sci; 1990; 613():95-108. PubMed ID: 2076022
[No Abstract] [Full Text] [Related]
40. Amino acids of the 6C3HED lymphosarcoma following treatment with asparaginase.
Ryan WL; Dworak JE
Cancer Res; 1970 Apr; 30(4):1206-9. PubMed ID: 4926800
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
